← back to search

Mike Hernández

Palo Alto University · US
Area of research
Immunology · Radiology, Nuclear Medicine and Imaging
Research interest
Research interests include Medicine, Retrospective cohort study, Septic shock, Internal medicine, Sepsis, and Perioperative.
h-index
citations
391
works
8
NIH funding
primary concept
email

Recent publications

Hardware-efficient quantum error correction via concatenated bosonic qubits
Nature 2025cited by 81position: middledoi
Proton versus photon radiotherapy for patients with oropharyngeal cancer in the USA: a multicentre, randomised, open-label, non-inferiority phase 3 trial
The Lancet 2025cited by 20position: middledoi
Phase III randomized trial of intensity-modulated proton therapy (IMPT) versus intensity-modulated photon therapy (IMRT) for the treatment of head and neck oropharyngeal carcinoma (OPC).
Journal of Clinical Oncology 2024cited by 43position: middledoi
A Multicenter Open-Label Randomized Phase II Study of Osimertinib With and Without Ramucirumab in Tyrosine Kinase Inhibitor–Naïve <i>EGFR</i> -Mutant Metastatic Non–Small Cell Lung Cancer (RAMOSE trial)
Journal of Clinical Oncology 2024cited by 42position: middledoi
Outcomes and Predictors of 28-Day Mortality in Patients With Hematologic Malignancies and Septic Shock Defined by Sepsis-3 Criteria
Journal of the National Comprehensive Cancer Network 2022cited by 51position: middledoi
Outcomes and Predictors of 28-Day Mortality in Patients With Solid Tumors and Septic Shock Defined by Third International Consensus Definitions for Sepsis and Septic Shock Criteria
CHEST Journal 2022cited by 38position: middledoi
Implementation of an Enhanced Recovery After Spine Surgery program at a large cancer center: a preliminary analysis
Journal of Neurosurgery Spine 2018cited by 116position: middledoi
Immersive technological approaches to managing perceived pain in pediatric patients undergoing vascular access procedures
Journal of Pain 2018cited by 0position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 2 papers (2022–2022)Cristina Gutiérrez · NewYork–Presbyterian Hospital2 papers (2022–2022)Charles L. Sprung · Hebrew University of Jerusalem2 papers (2022–2022) · 2 papers (2022–2022) · 2 papers (2022–2022) · 2 papers (2022–2022) · 2 papers (2022–2022)Kristen Price · University of Kentucky2 papers (2022–2022)Mark W. McDonald · University of Alabama at Birmingham1 papers (2024–2024)Andrea Rodríguez-Restrepo · University of Arizona1 papers (2018–2018)Thomas J. Caruso · Palo Alto University1 papers (2018–2018)Joseph L. Nates · The University of Texas MD Anderson Cancer Center1 papers (2022–2022)Erich M. Sturgis · Roswell Park Comprehensive Cancer Center1 papers (2024–2024)Steven J. Frank · Hebrew University of Jerusalem1 papers (2024–2024)Renata Ferrarotto · The University of Texas MD Anderson Cancer Center1 papers (2024–2024) · 1 papers (2018–2018) · 1 papers (2024–2024)Joseph L. Nates · University of Houston1 papers (2022–2022)J.W. Snider · University of Alabama at Birmingham1 papers (2024–2024) · 1 papers (2022–2022)